Abstract Decarboxylation of malonyl-CoA to acetyl-CoA by malonyl-CoA decarboxylase (MCD; EC 4.1.1.9) is a vital catalytic reaction of lipid metabolism. While it is established that phosphorylation of MCD modulates the enzymatic activity, the specific phosphorylation sites associated with the catalytic function have not been documented due to lack of sufficient production of MCD with proper post-translational modifications. Here, we used the silkworm-based Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid system to express human MCD (hMCD) and mapped phosphorylation effects on enzymatic function. Purified MCD from silkworm displayed post-translational phosphorylation and demonstrated coherent enzymatic activity with high yield (−200 μg/silkworm). Point mutations in putative phosphorylation sites, Ser-204 or Tyr-405 of hMCD, identified by bioinformatics and proteomics analyses reduced the catalytic activity, underscoring the functional significance of phosphorylation in modulating decarboxylase-based catalysis. Identified phosphorylated residues are distinct from the decarboxylation catalytic site, implicating a phosphorylation-induced global conformational change of MCD as responsible in altering catalytic function. We conclude that phosphorylation of Ser-204 and Tyr-405 regulates the decarboxylase function of hMCD leveraging the silkworm-based BmNPV bacmid expression Electronic supplementary material The online version of this article
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Introduction
Malonyl-CoA decarboxylase (MCD, E.C.4.1.1.9), encoded by MLYCD, is the crucial metabolic enzyme responsible for sustaining homeostatic lipid metabolism (Dyck et al. 2006; Folmes et al. 2013; Saggerson 2008) . Due to the importance of cellular functions in fatty acid metabolism, MCD is ubiquitously expressed in all living organisms locating in mitochondria, peroxisome, and cytoplasm (Buckner et al. 1976; Kim et al. 1979; Scholte 1969) . In humans, deficiency of MCD (OMIM 248360) precipitates a spectrum of disorders including cardiomyopathy, hypoglycemia, hypotonia, mild mental retardation, metabolic acidosis, malonic aciduria, seizures, and vomiting (Brown et al. 1984; Haan et al. 1986; Krawinkel et al. 1994; MacPhee et al. 1993; Matalon et al. 1993; Xue et al. 2012; Yano et al. 1997) .
MCD participates in the degradation of malonyl-CoA, an integral metabolic intermediate in anabolic/catabolic lipid metabolism (Figs. S1 and S2, Supporting Information). MalonylCoA is a committed substrate for de novo fatty acid biosynthesis, yet abundant malonyl-CoA inhibits carnitine palmitoyltransferase 1 (CPT-1), a rate-limiting step for longchain fatty acid transport into mitochondria and subsequent lipid β-oxidation (Kim et al. 1989; Pender et al. 2006) . Inhibition of MCD reduces fatty acid β-oxidation and accelerates glucose oxidation, producing a metabolic switch in energy substrate preference (Dyck et al. 2006) . Consequently, regulation of MCD activity to modulate intracellular malonyl-CoA levels is considered for potential therapeutic applications to mitigate metabolic disorders.
Post-translational modification of MCD modulates enzymatic function (Dyck et al. 2000; Laurent et al. 2013; Park et al. 2002; Saha et al. 2000; Sambandam et al. 2004; Voilley et al. 1999) . For example, MCD has several acetylation sites, and MCD deacetylation inhibits the decarboxylase activity thereby promoting de novo lipogenesis, whereas MCD acetylation enhances fatty acid oxidation (Laurent et al. 2013) . In contrast, the catalytic activity associated with MCD phosphorylation/dephosphorylation has not been definitively documented as phosphorylation sites have not been identified and production of sufficient authentic MCD with suitable post-translational modification remains limited (Dyck et al. 2000; Park et al. 2002; Saha et al. 2000; Sambandam et al. 2004; Voilley et al. 1999) .
The E. coli expression system has been widely used for recombinant protein production, yet the proteins expressed in this system often show poor post-translational modifications (Kamionka 2011) . To secure genuine eukaryotic protein production with proper post-translational modifications, a Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid, a hybrid shuttle vector for an E. coli and B. mori, has been developed (Kato et al. 2010; Motohashi et al. 2005) . With this system, we have successfully produced cellular, mitochondrial, and membrane proteins with proper folding and posttranslational modifications (Fig. S3 , Supporting Information) (Dojima et al. 2009; Du et al. 2009; Hwang et al. 2014) .
Here, we examined whether phosphorylation of human MCD (hMCD) generated using the silkworm-based BmNPV bacmid expression system modulates the essential decarboxylase activity. We report that the recombinant hMCD displays phosphorylation properties with consistent catalytic activity. Point mutations in the phosphorylation sites, namely Ser-204 and Tyr-405, limit the enzymatic activity of hMCD, underscoring the regulation of catalytic function by phosphorylation. The silkworm-based BmNPV bacmid expression system thus provides a reliable recombinant eukaryotic protein production modality with proper post-translational phosphorylation suitable for functional analysis of human MCD.
Materials and methods
Construction of recombinant Δ39aa-hMCD BmNPV bacmid and mutants & The overall strategy for the construction and expression of Δ39aa-hMCD BmNPV bacmid is shown in Fig. 1 . The complementary DNA of hMCD from Mammalian Gene Collection (GenBank EAW95513.1, Thermo Scientific, Pittsburgh, PA, USA) was used as a template. N-terminal 39 amino acids of hMCD, a putative mitochondria targeting sequence, were deleted using conventional polymerase chain reaction (PCR) with a pair of primers containing the BamHI/XhoI restriction cloning site: 5′-GCGG ATCCCACCATGGACTACAAGGATGACGATGAC AAGATGGACGAGCTGCTGCGCCGC-3′ (forward), 5′-GCCTCGAGTCAGAGCTTGCTGTTCTTTTGAAA CTG-3′ (reverse). Deletion of the mitochondria targeting sequence leads to high protein expression and does not affect the enzyme activity (Zhou et al. 2004 ). In addition, the Kozak consensus sequence and the FLAG tag sequence were attached at N-terminus for high expression levels in baculovirus expression system and for purification of expressed protein, respectively. The PCR cycle was conducted following 40 cycles of denaturation at 98°C for 10 s, annealing at 55°C for 5 s, and extension at 72°C for 10 s using PrimeSTAR® Max premix kit (Takara Bio Inc., Otsu, Shiga, Japan). The resultant PCR product (Δ39aa-hMCD gene) was digested with BamHI and XhoI followed by purification with a GFX™ PCR DNA and Gel Band Purification Kit (GE Healthcare, Amersham, UK). The purified DNA fragment was ligated into pFastbac 1 vector, transformed into E. coli competent DH5α cells (Invitrogen, Carlsbad, CA, USA) and then cultured on a solid Luria-Bertani (LB) medium containing 100 μg/mL of ampicillin at 37°C for 18 h. The plasmid containing Δ39aa-hMCD gene was isolated, and its sequence identity was confirmed by DNA sequencing. Finally, E. coli BmDH10bac-CP − -Chi − competent cells containing the cysteine proteinase-and chitinase-deficient BmNPV bacmid (Park et al. 2008a) were transformed with the pFastbac1-Δ39aa-hMCD and cultured on a solid LB medium containing 50 μg/mL of kanamycin, 7 μg/mL of gentamycin, 10 μg/mL of tetracycline, 40 μg/mL of isopropyl β-D-1-thiogalactopyranoside (IPTG), and 100 μg/ mL of 5-bromo-4-chloro-3-indolyl-4-galactoside (X-Gal) (Takara Bio) at 37°C for 18 h (Fig. S3 , Supporting Information). To confirm the BmNPV-Δ39aa-hMCD, bacmid PCR of white colonies was assessed using M13 primers. The PCR cycle was conducted following 30 cycles of denaturation at 98°C for 10 s, annealing at 55°C for 10 s, and extension at 72°C for 40 s using SapphireAmp Fast PCR Master Mix kit (Takara Bio). The recombinant BmNPV bacmid (BmNPV-Δ39aa-hMCD) was isolated from positive colonies confirmed by bacmid PCR.
For the construction of mutated hMCD BmNPV bacmid (S204G and Y405F), the QuikChangeII XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was used accordi ng to t he manufact urer 's protocols. The pFastbac-Δ39aa-hMCDs containing the desired mutation were produced using the constructed pFastbac-Δ39aa-hMCD as a template by PCR reaction with primer sets containing changed base for mutation: 5′-GGGTTACCTGGC ATGGACCGTGTGAAGTGCTTC-3′ (forward primer for S204G), 5′-GAAGCACTTCACACGGTCCATGCCAG GTAACCC-3′ (reverse primer for S204G), 5′-AGGCTG TGCGCCTGGTTCCTGTATGGAGAGAAG-3′ (forward primer for Y405F), and 5′-CTTCTCTCCATACAGGAA CCAGGCGCACAGCCT-3′ (reverse primer for Y405F). The PCR cycle was conducted following 18 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 30s, and extension at 68°C for 6.5 min. After Dpn I treatment at 37°C for 3 h, Dpn I-treated plasmids were transformed into XL10-Gold ultracompetent cells (Stratagene). The plasmid 
. The constructed recombinant bacmid was directly injected into the dorsum of the larvae on the first day of their fifth-instar and pupae. M mitochondrial targeting sequence, K Kozak sequence, F FLAG tag, SKL peroxisomal targeting sequence. Black and green arrows denote bacmid constructions for Δ39aa-hMCD and for Δ39aa-hMCD mutants, respectively containing pFastbac-Δ39aa-hMCD mutant genes were isolated, and its sequence identity with mutation was confirmed by DNA sequencing.
Expression and purification of recombinant Δ39aa-hMCD in silkworm larvae and pupae
To produce a recombinant protein in silkworm, 10 μg of each recombinant BmNPV bacmid DNA was directly injected with DMRIE-C reagent (Invitrogen) into the dorsum of larvae and pupae using a syringe with a 26-gauge beveled needle (Terumo Co. Tokyo, Japan). The injected larvae and pupae were reared at 27°C in an incubator for 6-7 days. In the case of larvae, the fat body was collected by cutting and dissection. The samples including fat body or pupae were immediately frozen at −80°C until further analysis. Protein purification was carried out at 4°C to minimize aggregation and protease activity. The aliquot of collected larval fat body or pupae was homogenized in 10 mL of lysis buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4, and 0.1 % TritonX-100) containing an EDTA-free protease inhibitor tablet (Roche, Mannheim, Germany) using a homogenizer (GLH-115, Yamato, Tokyo, Japan). Cell debris was removed by pelleting through centrifugation at 12,000g for 30 min. The supernatant was filtered using a 0.45-μm syringe filter and loaded onto a 500-μL anti-FLAG M2 antibody affinity gel (Sigma-Aldrich, St. Louis, MO, USA) pre-equilibrated with equilibration buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4, and 0.02 % TritonX-100). The column was washed with 2.5 mL of equilibration buffer and eluted with elution buffer (100 μg/mL FLAG peptide in 50 mM Tris-HCl and 150 mM NaCl, pH 7.4). Purified protein concentration was determined using BCA protein assay kit (Thermo Scientific, Rockford, IL, USA).
SDS-PAGE and western blotting
The integrity of purified Δ39aa-hMCD was determined by Coomassie brilliant blue (CBB)-staining and western blotting analyses (Karger et al. 2008; Park et al. 2008b ). Prior to electrophoresis, purified samples were boiled for 5 min at 95°C with protein denaturing buffer (Nacalai Tesque, Kyoto, Japan). Samples were electrophoresed in a 10 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel with a Mini-PROTEAN system (Bio-Rad, Hercules, CA, USA) at 150 V for 45-60 min in Tris-glycine buffer (25 mM Tris, 250 mM glycine, pH 8.3, and 0.1 % SDS). After electrophoresis, the SDS-PAGE gel was stained with Coomassie blue staining solution. For western blotting analysis, the separated proteins on a SDS-PAGE gel were transferred to PVDF membranes (GE Healthcare) by electroblotting on a semi-dry blotter (Bio-Rad) at 15 V for 1 h. To detect the purified Δ39aa-hMCD and their phosphorylation, a mouse anti-FLAG antibody (Wako Pure Chem. Industries Ltd., Osaka, Japan), anti-phosphoserine antibody, and anti-phosphotyrosine (Sigma-Aldrich) were used as primary antibodies, respectively. A horseradish peroxidaseconjugated anti-mouse immunoglobulin-G (IgG-HRP) (GE Healthcare) was used as a secondary antibody in both cases.
MCD activity assay
The hMCD activity was measured by the production of reduced nicotinamide adenine dinucleotide (NADH) in the coupled reactions (Kim and Kolattukudy 1978) . The NADH is accumulated by the reaction of acetyl-CoA from malonylCoA and oxaloacetate from malate (Eqs. 1-3).
Malate þ NAD !
Malate dehydrogenase
Oxaloacetate þ NADH ð2Þ
To measure the decarboxylase activity of recombinant hMCD, 10 μg of purified Δ39aa-hMCD was incubated with 36 μL of reaction buffer (10 mM of Tris-HCl, pH 7.5, 2 mM of malate, 2 mM of NAD, 0.8 U of malate dehydrogenase) at room temperature. After 5 min, assay was initiated by the addition of 3 mM of malonyl-CoA and incubated at 37°C. After 10 min, 0.03 U of citrate synthase was added to the incubated solution. The reaction was terminated by addition of 4 μL of 100 % trichloroacetic acid. The produced NADH during reaction was detected using an UV-visible spectrophotometer by measuring the absorbance at 340 nm.
Results

Expression and purification of Δ39aa-hMCD
The hMCD harbors a mitochondrial targeting sequence (39 amino acids) at N-terminus and a peroxisomal targeting sequence (Ser-Lys-Leu, SKL) at C-terminus (Fig. 1) . The peroxisomal SKL residues do not affect the protein expression levels, but the mitochondrial targeting sequence significantly diminishes MCD expression (Voilley et al. 1999) . Therefore, we designed a construct without a mitochondrial targeting sequence but retaining the peroxisomal SKL sequence to enhance the recombinant hMCD production (Fig. 1) . The recombinant Δ39aa-hMCD with an N-terminal FLAG tag was expressed in silkworm larvae and pupae and purified using an anti-FLAG M2 affinity gel column. The purified Δ39aa-hMCD protein with more than 95 % purity migrated to −50 kDa, an estimated molecular weight on SDS-PAGE based on comparison with molecular weight markers (Fig. 2a) . Western blot analysis using a FLAG-specific antibody confirmed the specific expression of Δ39aa-hMCD (Fig. 2b) . In mock-injected silkworm, however, hMCD bands were not detected in both fat body and pupae samples (Fig. 2b) . Thus, the recombinant Δ39aa-hMCD purified here demonstrated significant homogeneity suitable for biochemical and functional analyses.
Silkworm-based recombinant protein expression conventionally provides a high yield of purified proteins in the range of 20-500 μg/silkworm (Table 1) . Consistent with this, the average yields of purified Δ39aa-hMCD from 10 silkworm larvae and 5 pupae were 119 μg/larva and 344 μg/pupa. The pupae-based protein expression provided a higher yield of purified protein than the fat body-based expression, probably due to the difference of organ size and protease activity in the expression host. Specific activities of the purified Δ39aa-hMCD, measured by the production of NADH in the coupled reactions, were 59.54±7.68 nmol/mg/min (n=6) from silkworm fat body and 48.16±7.89 nmol/mg/min (n=6) from silkworm pupae (Table 2 ). These measured enzymatic activities showed no significant statistical difference (p>0.05), but are much higher than that of human recombinant MCD purified from E. coli (Zhou et al. 2004) indicating that the posttranslational modifications implemented in silkworms regulate catalytic activity. (Dyck et al. 1998; Park et al. 2002; Saha et al. 2000) , yet these studies provided inconsistent results of either a decrease or increase in decarboxylase activity of MCD. To clarify the phosphorylation-induced effects on MCD enzymatic function, potential phosphorylation sites of hMCD were examined. NetPhos 2.0, neural network predictions for serine, threonine, and tyrosine phosphorylation in eukaryotic proteins (http://www.cbs.dtu.dk/services/ NetPhos/), was applied to predict hMCD phosphorylation sites (Blom et al. 1999) (Fig. 3a) . Four serine , four threonine (Thr-9, Thr-60, Thr-245, and Thr-396), and one tyrosine (Tyr-468) residues were putatively identified as phosphorylation sites, which are well conserved (Fig. 3a, b) . Typically, each phosphorylation prediction program maps slightly different potential amino acid residues depending on bioinformatics Fig. 2 SDS-PAGE (a) and western blot (b) of recombinant Δ39aa-hMCD expressed in silkworm fat body and pupae. MW molecular weight markers, FB Δ39aa-hMCD from fat body, P Δ39aa-hMCD from pupae. Protein in homogenate was extracted with lysis buffer and purified by anti-FLAG M2 affinity gel column. Mock sample indicates bacmid, without hMCD gene, injected silkworm. An anti-FLAG M2 and an anti-mouse IgG-HRP were used to detect Δ39aa-hMCD, and an antiphosphoserine antibody was used to detect phosphorylation of Δ39aa-hMCD algorithm. Based on the NetPhos 2.0 prediction with nine amino acid residues as potential phosphorylation sites, we performed the mass spectrometry analysis to narrow down the proteomic search and identified exclusive phosphorylation of Ser-204 and Tyr-405 in the recombinant Δ39aa-hMCD, thereby excluding the investigation of other predicted phosphorylation sites. Accordingly, these residues were mutated to glycine (S204G) and phenylalanine (Y405F) using site-directed mutagenesis to eliminate the hydroxyl group for phosphorylation (Fig. 3c) . The point mutants S204G and Y405F were purified from silkworm fat body and pupae and analyzed by western blotting using an anti-phosphoserine and anti-phosphotyrosine antibodies (Fig. 4) . The Δ39aa-hMCD mutants displayed a substantial decrease on western blotting analysis compared with the wild type Δ39aa-hMCD, indicating that Ser-204 
Phosphorylation-induced catalytic function of Δ39aa-hMCD
T h e c a t a l y t i c a c t i v i t y o f M C D a s s o c i at e d w i t h phosphorylation/dephosphorylation was previously evaluated
(A) Fig. 3 Amino acid sequence alignments of human, rat, and mouse MCD. a Blue, two initiating methionines; Red, putative phosphorylation site residues of hMCD by NetPhos 2.0 prediction server; Arrow, point mutation sites for dephosphorylation of hMCD in this study. b
Predicted phosphorylation sites of hMCD. Prediction score is the probability of phosphorylation (max=1). c A point mutation in hMCD replaced serine (S) 204 (codon TCA) with glycine (G) (codon GGA) and tyrosine (Y) 405 (codon TAC) with phenylalanine (F) (codon TTC) and Tyr-405 are indeed the residues for phosphorylation. The lack of complete absence of the phosphorylated MCD band in western blotting, however, could be ascribed to phosphorylated amino acid residues other than Ser-204 and Tyr-405.
To evaluate the effect of phosphorylation on the biological function of hMCD, the decarboxylase activity of Δ39aa-hMCD mutants was measured. The specific activities of S204G mutant purified from fat body and pupae were 30.36 ±2.25 (n=6) and 24.37±1.99 nmol/mg/min (n=6), respectively, which are lower by 50 % than that of wild type Δ39aa-hMCD (Table 3 ). In addition, the specific activities of Y405F mutants were 33.45 ± 3.56 (n = 6) and 31.24 ± 1.69 nmol/mg/min (n=6) purified from fat body and pupae, respectively. Collectively, the dephosphorylation of hMCD diminishes decarboxylase activity, underlining the phosphorylation-induced regulation in catalytic function.
Structural implication of hMCD phosphorylation
The resolved crystal structure of hMCD (Protein Data Bank (PDB) accession number: 4F0X) reveals a molecular tetramer, composed by a dimer of structural heterodimer where the two subunits show different conformations (Fig. 5) (Aparicio et al. 2013) . The monomer of MCD has an N-terminal helical domain for oligomerization and a C-terminal domain for catalysis, and the active site of MCD is located in a prominent groove clustered with evolutionarily conserved residues (Fig. 5a) (Aparicio et al. 2013; Froese et al. 2013) . Through inter-subunit disulfide bonds, (Fig. 5b) , the four subunits of the tetramer are connected, providing positive cooperativity to the decarboxylase catalytic function (Aparicio et al. 2013) .
Ser-204 identified here for the phosphorylated residue is located in the beginning of the catalytic domain. The side chain of Ser-204 is fully exposed to solvent in the monomeric structure ( Fig. 5a and c) , and −20 Å is away from the active site, suggesting that the phosphorylation could not directly affect the structural integrity of the catalytic active site. However, the quaternary structure of hMCD reveals that Ser-204 is located nearby the Cys-206, the essential residue for the intersubunit disulfide bond interaction (Fig. 5c) . Thus, the phosphorylation/dephosphorylation of Ser-204 might modulate the disulfide bridge formation, contributing to the catalytic function. Moreover, as Lys-210 (rat sequence; Lys-211 in human) has been reported to be an essential amino acid residue for rat MCD enzymatic function through acetylation (Nam et al. 2006) , the post-translational modifications in the vicinity of Cys-206 could be a key player in regulation of MCD function.
In contrast to Ser-204, Tyr-405 is not in the vicinity of intersubunit interactions. This residue is located near to the catalytic dyad with His-423 and Ser-329. The hydroxyl group of Tyr-405 forms a hydrogen bond with the side chain of Asn-417, which is in the same α-helix harboring catalytic His-423 (Fig. 5d) . Based on this structural information, the phosphorylation of Tyr-405 might induce the conformational change of a catalytic dyad producing the fine-tuning in decarboxylase activity.
Discussion
Malonyl-CoA decarboxylase is a metabolic enzyme participating in the production of acetyl-CoA from malonyl-CoA, a vital metabolite for anabolic fatty acid biosynthesis and catabolic lipid oxidation (Dyck et al. 1998; Pender et al. 2006) . MCD overexpression increases fatty acid oxidation and Western blot of purified Δ39aa-hMCD and their mutants. MW molecular weight markers, WT wild type Δ39aa-hMCD, S204G mutated Δ39aa-hMCD at serine 204, Y405F mutated Δ39aa-hMCD at tyrosine 405. FB and P denote proteins purified from fat body and pupae, respectively. A monoclonal anti-phosphoserine and antiphosphotyrosine antibodies produced in mouse were used as primary antibodies, and anti-mouse IgG-HRP was used as a secondary antibody. In western blot, 5 μg of proteins per well were used improves whole body insulin resistance , whereas reduced MCD levels decrease lipid oxidation with an increase in glucose oxidation in human myotubes (Bouzakri et al. 2008 ). In addition, catalytic function of MCD is regulated by multiple factors including posttranslational modifications (Dyck et al. 2000; Nam et al. 2006; Park et al. 2002; Saha et al. 2000) . Due to the pathophysiological relevance of MCD in metabolism-associated disorders, the regulation of MCD activity has been increasingly recognized as a candidate target for therapeutic interventions, essentially requiring authentic heterologous protein production to map critical molecular entities (Sambandam et al. 2004; Saggerson 2008) . Here, we successfully produced recombinant hMCD using the silkworm-based BmNPV expression system equipped with proper post-translational modification machinery. The heterologous MCD from silkworm demonstrated an essential and higher decarboxylase activity compared to that of MCD from E. coli (Zhou et al. 2004) , underscoring the enzymatic activity enhancement by posttranslational modifications implemented in silkworm. Furthermore, we identified two critical phosphorylated residues of Ser204 and Tyr-405 involved in regulation of decarboxylase-based catalysis. AMP-activated protein kinase (AMPK) has been suggested to regulate MCD activity. Phosphorylation of MCD by AMPK promotes the enzymatic activity, leading to a decrease in the malonyl-CoA levels, whereas dephosphorylation inhibits the catabolic function (Park et al. 2002; Saha et al. 2000) . Up to date, several putative phosphorylation sites on serine, threonine, and tyrosine residues have been suggested, (Voilley et al. 1999 ), yet critical phosphorylation residues affecting the human MCD activity have remained elusive. By utilizing bioinformatics and mass spectrometry analyses, we identified exclusive phosphorylation of Ser-204 and Tyr-405. Point mutations of the phosphorylation sites decreased specific activity of hMCD, highlighting the biological significance of Ser-204 and Tyr-405 in regulating decarboxylase activity.
In summary, silkworm-based BmNPV protein expression system successfully produced the human MCD with high yield and post-translation modification. Heterologous MCD retains essential decarboxylase activity and harbors two post-translational phosphorylation residues, namely Ser-204 and Tyr-405, critical in modulating MCD catalytic function. Identified phosphorylated residues are distinct from the decarboxylation catalytic site, implicating a phosphorylationinduced global conformational change of MCD as responsible in altering catalytic function. Collectively, our findings demonstrate that phosphorylation modulates decarboxylase-based catalytic function of MCD levering the silkworm-based BmNPV expression system that offers a fail-safe eukaryotic bioengineered protein production platform implementing phosphorylation. Furthermore, authentic recombinant proteins produced from silkworm could be used for functional and structural studies including high-throughput therapeutic drug discovery application.
